首页> 外文会议>IWA(International Water Association) Specialised Conference on Assessment and Control of Hazardous Substances in Water(ECOHAZARD2003); 20030914-17; Aachen(DE) >Carbamazepine, diclofenac, ibuprofen and bezafibrate-investigations on the behaviour of selected Pharmaceuticals during wastewater treatment
【24h】

Carbamazepine, diclofenac, ibuprofen and bezafibrate-investigations on the behaviour of selected Pharmaceuticals during wastewater treatment

机译:卡马西平,双氯芬酸,布洛芬和苯扎贝特对废水处理中某些药物行为的研究

获取原文
获取原文并翻译 | 示例

摘要

Numerous investigations in different European countries observed various pharmaceutically active compounds (PhACs) in notable concentrations in the aquatic environment. Further determinations found the effluents of sewage treatment plants (STPs) to be significant sources for the entry of pharmaceutical residuals to rivers, streams and surface waters. Due to those pathways the knowledge about the elimination of these substances and their behaviour in wastewater treatment plants (WWTP) is elementary for protection of an intact aquatic environment. Since the sludge retention time (SRT) is the most important parameter for the design of STPs, its influence on the reduction rate of these PhACs in the wastewater treatment process was investigated. To study this influence of the SRT on the elimination of PhACs, lab scale plants have been operated with different sludge retention times. The results of the laboratory experiments have been validated analysing various STPs within a wide capacity range and operating at different SRTs. This report describes the determinations observed on the antiepileptic drug Carbamazepine, the two antiphlogistics and analgesics Diclofenac and Ibuprofen and the lipid regulator Bezafibrate.
机译:在欧洲不同国家进行的大量研究发现,在水生环境中,各种药物活性化合物(PhAC)的浓度均很高。进一步的确定发现,污水处理厂(STP)的废水是造成药物残留物进入河流,溪流和地表水的重要来源。由于这些途径,有关在污水处理厂(WWTP)中消除这些物质及其行为的知识对于保护完整的水生环境至关重要。由于污泥保留时间(SRT)是STP设计的最重要参数,因此研究了其对废水处理过程中这些PhAC还原速率的影响。为了研究SRT对消除PhAC的影响,已对实验室规模的装置进行了不同的污泥保留时间操作。实验室实验的结果已得到验证,可以分析大容量范围内的各种STP并以不同的SRT运行。该报告描述了对抗癫痫药卡马西平,两种抗炎镇痛药双氯芬酸和布洛芬以及脂质调节剂苯扎贝特的观察结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号